Clinical Trial Detail

NCT ID NCT01776307
Title A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Cetuximab + Napabucasin

Capecitabine + Napabucasin

Napabucasin + Panitumumab

Age Groups: adult senior

No variant requirements are available.